Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations and Comprehensive Loss

v3.19.2
Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2019
Jun. 30, 2018
Jun. 30, 2019
Jun. 30, 2018
Operating expenses:        
Research and development $ 21,119 $ 14,397 $ 39,707 $ 23,874
General and administrative 4,529 3,574 10,192 6,947
Total operating expenses 25,648 17,971 49,899 30,821
Loss from operations (25,648) (17,971) (49,899) (30,821)
Other income (expense):        
Interest income 1,610 1,061 2,786 1,769
Interest expense   (128)   (336)
Loss on extinguishment of debt   (407)   (407)
Other expense, net   (86)   (4,741)
Total other income (expense) 1,610 440 2,786 (3,715)
Net loss (24,038) (17,531) (47,113) (34,536)
Other comprehensive income (loss):        
Unrealized gain (loss) on marketable securities 183 65 286 (23)
Total other comprehensive income (loss) 183 65 286 (23)
Comprehensive loss $ (23,855) $ (17,466) $ (46,827) $ (34,559)
Basic net loss per common share $ (0.35) $ (0.30) $ (0.72) $ (0.61)
Diluted net loss per common share $ (0.35) $ (0.30) $ (0.72) $ (0.61)
Weighted average common shares outstanding used to calculate basic net loss per common share 68,697,735 58,833,647 65,312,988 56,307,236
Weighted average common shares outstanding used to calculate diluted net loss per common share 68,697,735 58,905,898 65,312,988 56,307,236